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Abstract
Tissue homeostasis is controlled by signaling systems that coordi-
nate cell proliferation, cell growth and cell shape upon changes in
the cellular environment. Deregulation of these processes is associ-
ated with human cancer and can occur at multiple levels of the
underlying signaling systems. To gain an integrated view on
signaling modules controlling tissue growth, we analyzed the inter-
action proteome of the human Hippo pathway, an established
growth regulatory signaling system. The resulting high-resolution
network model of 480 protein-protein interactions among 270
network components suggests participation of Hippo pathway
components in three distinct modules that all converge on the
transcriptional co-activator YAP1. One of the modules corresponds
to the canonical Hippo kinase cassette whereas the other two both
contain Hippo components in complexes with cell polarity
proteins. Quantitative proteomic data suggests that complex for-
mation with cell polarity proteins is dynamic and depends on the
integrity of cell-cell contacts. Collectively, our systematic analysis
greatly enhances our insights into the biochemical landscape
underlying human Hippo signaling and emphasizes multifaceted
roles of cell polarity complexes in Hippo-mediated tissue growth
control.
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Introduction
Development of metazoan tissues and organs depends on tight
control of proliferation, cell growth and programmed cell death in
response to extracellular and intracellular signals. Genetic and
biochemical experiments originally performed in Drosophila
melanogaster led to the discovery of the Hippo (Hpo) pathway, a con-
served signaling cascade that controls tissue and organ homeostasis
inmetazoans. Its core components are conserved in humans and have
been implicated in a variety of human cancers (Pan, 2010; Zhao et al,
2010; Harvey et al, 2013). These include the STE20 kinases MST1 and
MST2 (orthologs of the Drosophila Hpo kinase) which bind to SAV1
(WW45), the AGC kinase LATS1 (Large tumor suppressor homolog 1)
and its associated scaffold proteins MOB1A/B (Harvey & Tapon,
2007; Pan, 2007). Downstream of this kinase cascade are the WW-
domain-containing transcriptional co-activators YAP1 and TAZ (Dong
et al, 2007; Zhao et al, 2007; Lei et al, 2008) the two major effectors
of the Hpo pathway. Active MST1/2 in complex with SAV1 phospho-
rylates LATS1/2, which in turn stimulates LATS-MOB complex forma-
tion and activation of LATS kinase activity. Active LATS1/2 kinases
phosphorylate and inactivate YAP1 and TAZ through 14-3-3 protein-
mediated cytoplasmic sequestration (Dong et al, 2007; Guo et al,
2007; Zhao et al, 2007; Lei et al, 2008; Oka et al, 2008; Zhang et al,
2008). When the Hpo pathway is inactive, hypo-phosphorylated
nuclear YAP1 and TAZ bind to the TEA domain transcription factors
(TEAD1/2/3/4) to drive expression of pro-growth and anti-apoptotic
genes (Wu et al, 2008; Zhao et al, 2008).
While the signaling mechanism for the Hpo core module is well-
established, our understanding of the physiological cues, signaling
components and mechanisms that control the activation and repres-
sion of the human Hpo pathway is still quite limited. Recent genetic
data from Drosophila and biochemical analysis in human cells
suggest that Hpo signaling is linked to cell polarity, the cytoskeleton
and cell junctions (Genevet & Tapon, 2011; Schroeder & Halder,
2012). However, the molecular complexes that transmit polarity and
cytoskeletal signals to the Hpo core modules are just beginning to
emerge and there is debate as to whether these are dependent on
the core cascade or if they act directly on YAP1.
Since most proteins exert their function in the context of specific
protein complexes, the characterization of complexes involving
genetically defined Hpo components turned out to be a particularly
successful approach to uncover novel regulators and mechanisms
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underlying the control of tissue growth by the Hpo signaling net-
work. Affinity purification coupled to mass spectrometry (AP-MS)
has proven to be a sensitive tool for the identification of novel
protein interactions under physiological conditions (Rigaut et al,
1999; Gingras et al, 2007; Gstaiger & Aebersold, 2009; Pardo & Cho-
udhary, 2012). Using a combined AP-MS and genomics approach
we recently identified dSTRIPAK, a serine/threonine phosphatase
complex that associates with Hpo kinase and negatively regulates
Hpo signaling in Drosophila (Ribeiro et al, 2010). AP-MS also
revealed the regulatory interaction between the FERM domain pro-
tein Expanded (Ex) and the co-activator Yorkie (Yki) in Drosophila
(Badouel et al, 2009) and the presence of cell-cell junction proteins
(AMOT, AMOTL1, AMOTL2) in human YAP and TAZ complexes
(Varelas et al, 2010; Wang et al, 2011; Zhao et al, 2011). The few
isolated AP-MS studies performed so far used different technologies
in different cellular systems, which make it difficult to integrate the
available data towards a coherent model of the protein interaction
landscape underlying Hpo signaling. Such integrative models are
however important, as the control of tissue and organ size can
hardly be attributed to just single signaling components, but more
likely emerges from concerted molecular events of a complex
signaling network. Significant advances in protein complex
purification and mass spectrometry instrumentation permit robust
characterization of larger groups of complexes and entire pathways,
even from human cells (Sardiu et al, 2008; Sowa et al, 2009;
Behrends et al, 2010; Glatter et al, 2011; Varjosalo et al, 2013).
Here, we describe the systematic characterization of the protein
landscape for the human Hpo pathway. Stringent scoring and
cluster analysis of obtained AP-MS data revealed 480 high-
confidence interactions among 270 network components that con-
firm many previously known protein interactions found in humans
and interactions of orthologs in other species and provide novel
biochemical context for Hpo pathway components. Hierarchical
clustering of the obtained interaction data revealed a system of
three major signaling modules linked to the transcriptional co-acti-
vator YAP1. Aside from the Hpo core kinase complex, the remain-
ing two modules provide multiple links to apico-basal cell polarity
(ABCP) and planar cell polarity (PCP). We identified the PP1-
ASPP2 module as a regulatory element in controlling transcrip-
tional output of the Hpo pathway and show that polarity proteins
differentially bind YAP1 depending on cell-cell contacts. The pre-
sented data represents a rich biochemical framework providing
343 previously unidentified high-confidence protein interactions
for established pathway components, which will be important for
directing future functional experiments to better model tissue
growth by the Hpo pathway. The results furthermore support the
notion that transcriptional outputs of the major Hpo effector YAP1
may involve a number of biochemical processes linked to cell
polarity that may act in parallel to or independent of the canonical
Hpo core kinase cassette.
Results
Characterization of the human Hpo interaction proteome by a
systematic AP-MS approach
To resolve the interaction proteome underlying humanHpo signaling,
we selected nine conserved core pathway components as initial baits
for AP-MS analysis in HEK293 cells, based on previously described
workflow (Glatter et al, 2009). This initial bait set included the human
Hpo kinases MST1 andMST2, the MOB kinase activator 1B (MOB1B),
the transcriptional co-activator YAP1, the transcription factor TEAD3,
as well as human orthologs of Drosophila Hpo pathway regulators
FRMD6 (Willin; homolog of Expanded, Ex), the tumor suppressor
protein MERL (homolog of Drosophila Merlin) (Hamaratoglu et al,
2006), and the WW-domain protein KIBRA (Yu et al, 2010). From the
interacting proteins identified in this first round of AP-MS experi-
ments we subsequently selected 26 additional secondary bait pro-
teins. Altogether we analyzed 90 AP-MS samples covering 34 bait
proteins with at least two biological replicates (Fig 1A and B; Supple-
mentary Table S1). We identified a total of 835 proteins at a protein
false discovery rate (FDR) of < 1%. To differentiate between high-
confidence interacting proteins (HCIPs) and nonspecific contami-
nants, we filtered our dataset based on WDN-score calculations
(Behrends et al, 2010) and relative protein abundance compared to
control purification experiments, estimated by normalized spectral
counting (Paoletti et al, 2006; Zybailov et al, 2006) (Fig 1C). The data
filtering yielded a final network of 270 HCIPs and 480 corresponding
interactions (Supplementary Table S2). 88% of these high-confidence
interactions have been repeated in all replicate experiments per-
formed (which includes duplicates, triplicates and quadruplicates).
Eighty-six percent of the interactions tested by co-immunoprecipita-
tion and Western blotting could be experimentally validated (Supple-
mentary Figure S1), which corresponds well to the experimental
validation rate reported in previous large scale AP-MS studies (Sowa
et al, 2009; Behrends et al, 2010; Varjosalo et al, 2013). On average,
we identified 14.7 HCIPs for each bait, which corresponds to the num-
ber of interactors typically found in similar AP-MS studies (Sowa
et al, 2009; Behrends et al, 2010; Varjosalo et al, 2013). We also com-
pared the obtained high-confidence AP-MS data set with protein inter-
action (PPI) data annotated in public databases. 71.5% of our
interactions have not been reported at the time of submission and, as
expected, the fraction of newly identified PPI varied substantially for
the different bait proteins tested (Fig 1E). Well-studied proteins (e.g.
MST1, MST2, STRN, STRN3, AMOT, PP1G, RASF1) had a larger frac-
tion of previously annotated interaction partners than less intensively
studied proteins (e.g. E41L3, RASF10, RASF9, FRMD5).
Inspection of public PPI data (including yeast two-hybrid and
in vitro binding assays) for the 34 baits analyzed in our study
resulted in a network of 516 proteins and 719 protein interactions
(Supplementary Table S3). 16% of these interactions were found in
our AP-MS dataset, which corresponds to 137 known protein inter-
actions. 84.6% of public interactions are reported by a single publi-
cation (Supplementary Figure S2A) and the FDR of public PPI data
is largely unknown. Therefore we used the number of independent
literature reports that support a given interaction as a proxy for data
confidence. When we compared our data with a high-confidence
subset of public PPI data (> 1 publication per interaction) our recall
rate increased to 36% (Fig 1D). The fraction of high-confidence
public interactions matching with our AP-MS data set was three
times higher than the one for the public PPI data not identified in
our study, demonstrating the overall robustness of the presented
PPI data (Supplementary Figure S2B). Further inspection of the
experimental sources of matching public PPI data revealed that two-
thirds of the data were obtained by other AP-MS studies (Supple-
mentary Figure S2C). At least 28 independent publications were
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needed to cover the annotated 137 interactions also identified in our
study. Remarkably, given the collective efforts in the biochemical
analysis of this pathway in the past we identified 170 interacting
proteins (Supplementary Figure S2D) and 343 interactions for Hpo
pathway components that so far were not annotated in public data-
bases, which provide important new clues for understanding the
molecular mechanisms underlying Hpo signaling in human cells.
Hierarchical clustering assigns Hpo pathway components to
interaction modules
Clustering of bait and prey proteins has been used successfully in the
past to infer modular proteome organization from systematic AP-MS
data (Sardiu et al, 2008). Hierarchical cluster analysis based on pro-
tein abundance of prey proteins relative to the corresponding bait
protein revealed three major clusters (hereafter referred to as ‘mod-
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Figure 1. A systematic affinity purification mass spectrometry (AP-MS) approach to define the human Hpo pathway interaction proteome.
A Selection of primary and secondary baits in this study. Baits were selected sequentially, starting with the core components of the Hpo kinase signaling pathway and
extended based on obtained AP-MS results or homology to Drosophila Hpo components.
B Biochemical workflow for native protein complex purification from HEK293-Flp T-rex cells. Bait proteins were expressed from a tetracycline-inducible CMV promoter,
with a N-terminal Strep-HA fusion tag following induction with doxycycline for 24 h. Cells were lysed, complexes affinity-purified and processed for analysis by
tandem mass spectrometry.
C Data analysis pipeline. Acquired mass spectra from 90 experiments (at least 2 biological replicates per bait) were searched with X!Tandem. Search results were
statistically validated by the Trans-Proteomic Pipeline (TPP) to match a protein identification false discovery rate of < 1%. High-confidence interactions were
obtained by filtering unspecific binding proteins based on a WDN-score threshold and comparison to control purification experiments (see also Materials and
Methods). The resulting high-confidence interactions were hierarchically clustered and visualized.
D Recall of known interactions from public protein interaction databases. The recall rate was higher, when compared to a more robust subset of literature interactions
that required more than one independent report per interaction.
E Overview on known and novel protein interactions identified in this study. Overall 71.5% of identified interactions have not yet been reported in public databases
and each bait associated on average with 14.7 proteins.
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3
ules’; Fig 2). The first module (‘Core Kinase Complex’) consists of
three interlinked sub-clusters: STRIPAK, a group of complexes con-
taining protein phosphatase 2A linked to Hpo kinase; SARAH, a clus-
ter containing all human SARAH domain proteins, including the
human Hpo kinases MST1 and MST2, and finally the MOB1-LATS
cluster. Collectively, this module consists of 61 proteins and 143
interactions. The second module (‘PP1-ASPP’) corresponds to a
single large cluster that is enriched for regulatory and catalytic
subunits of protein phosphatase 1 (PP1) and contains proteins
involved in apico-basal and planar cell polarity (ABCP and PCP). This
cluster consists of 90 proteins and 156 interactions. The third module
represents a highly interlinked network that consists of a set of Hpo
pathway members (L2GL1, DLG1, MERL, KIBRA, YAP1, TEAD) and
proteins linked to ABCP and hence referred to as ‘Polarity network’
(Fig 2B). This module consists of 72 proteins and 117 interactions.
We next analyzed the occurrence of structural domains (Inter-
Pro) across the 270 proteins found in the three modules and
performed a hierarchical clustering of these domains across all
purifications. The obtained domain cluster mirror the modular orga-
nization described above and thus revealed a characteristic enrich-
ment profile of structural domains for each of the modules. Overall
we noted a characteristic overrepresentation of specific domains,
such as WW, PDZ, FERM, L27 and SARAH (Supplementary Figure
S3A and B). Besides the apparent biochemical differences, all three
modules converge on the transcriptional co-activator and Yki homo-
log YAP1, the only protein connecting all three pathway modules.
B
A
HCIPs
SARAH
STRIPAK
PP1-ASPP
TEAD
R
AS
F6
ST
RN
PG
AM
5
TC
PG
TC
PE
TC
PZ
TC
PA
TC
PQ
TC
PH
TC
PB
CT
2N
L
TC
PD
CT
TB
2
2A
AB
ST
RN
4
PH
O
CN
FA
40
A
FA
40
B
M
ST
4
PD
C1
0
ST
RN
3
ST
K2
4
SI
KE
1
FG
O
P2
SL
M
AP
R
AS
F4
VA
PA
R
AS
F3
M
AP
1S
M
AP
1B
R
AS
F5
M
ST
2
M
ST
1
AN
XA
1
R
AS
F1
XP
O
6
R
AS
F2
SA
V1
CD
C3
7
ST
38
L
M
O
B1
A
M
O
B1
B
LA
TS
1
R
U V
B2
PP
1R
A
R
IF
1
IP
P2
PP
1G
PP
2B
B
CC
85
C
PP
1B
AS
PP
1
CC
85
B
CP
VL
R
AS
F8
PP
1A
AS
PP
2
PA
R
D
3
M
M
TA
2
R
AS
F1
0
PR
IC
3
CS
K2
B
D
D
B1
VA
N
G
1
ZA
2G
KC
M
F1
G
3B
P1
R
BB
P4
CY
TA
PC
BP
1
SP
R2
E
 
D
VL
3
D
VL
2
D
VL
1
R
AS
F9
SP
B3
CA
TD
G
G
CT
S1
0A
7
R
AS
F7
SR
RM
2
CS
K2
1
E4
1L
3
E4
1L
2
CA
DM
1
PI
42
B
LI
N
7A
M
PD
Z
M
PP
5
IN
AD
L
LI
N
7C
FR
M
D
6
14
33
T
14
33
B
14
33
F
14
33
G
H
S1
05
YA
P1
14
33
E
PT
N
14
KI
BR
A
AT
D
3A
D
YL
2
D
YL
1
AM
O
L1
AM
O
T
FR
M
D
5
TB
A1
C
M
ER
L
D
N
JA
1
D
N
JA
2
BA
G
5
L2
G
L1
CH
IP
M
CM
BP
TE
AD
3
FA
S
H
SP
74
FR
M
D
3
FRMD3
RASF10
RASF8
ASPP2
RASF7
RASF9
ASPP1
PP1G
SLMAP
STRN
STRN3
SAV1
RASF3
RASF5
RASF6
MST1
RASF4
RASF2
RASF1
MST2
MAP1S
TEAD3
L2GL1
MERL
AMOT
E41L3
YAP1
KIBRA
FRMD6
FRMD5
MPP5
LIN7A
ST38L
MOB1B
MOB1-LATS
ba
it 
pr
ot
ei
ns
SA
RA
H
ST
RI
PA
K
PP1-ASPP
PP1-ASPP Module Polarity Network
Polarity Network
TEAD
MOB1-LATS YAP1
MOB1BSTK38L
STRN
STRN3 SLMAP
MST1
MST2
RASF4
RASF2RASF5
SAV1
RASF6
RASF1
MAP1S
RASF3
ASPP2
ASPP1
RASF8
RASF7
PP1G
RASF10
RASF9
YAP1
TEAD3
YAP1
AMOT
KIBRA
MERL
E41L3
LIN7A
MPP5
L2GL1
ASPP2
Core Kinase Complex
protein abundance relative to the bait
0.0 1.0
Figure 2. Hierarchical clustering of bait and HCIPs reveals modular organization of the human Hpo pathway interactome.
A Cluster analysis AP-MS data. High-confidence interacting proteins (HCIPs) were clustered based on their abundance relative to the respective bait proteins by an
uncentered Pearson correlation algorithm using an average distance metric. Protein abundance relative to the bait is represented by the color-coded squares and
corresponds to the legend above the clustergram. Clustering suggests six modules for the Hpo interaction proteome that are organized in three major clusters.
Distinct modules are illustrated by colored frames and letters. Color of bait proteins and HCIP’s correspond to the respective modules they are part of. The ‘core
kinase complex’ contains the STRIPAK module, the SARAH module containing all SARAH domain proteins, including the Hpo kinase MST1 and MST2, and the
downstream kinase LATS1 and its adaptor proteins MOB1A/B (‘MOB1-LATS’ module). The ‘PP1-ASPP module’ contains all three PP1 catalytic and several regulatory
subunits. The ‘polarity network’ is defined by multiple polarity complexes, but also contains the transcription factor TEAD3 and the majority of proteins associated
with YAP1.
B Network representation of the obtained modules. The different modules and proteins therein are illustrated by the color scheme used above. Yap1 is the only protein
that is common to all three modules.
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Topology of the Hippo core kinase complex
Orthologs of the Drosophila proteins Hpo, Sav and Wts (MST1/2,
SAV1, LATS1/2) encode the highly conserved core kinase cassette
of the Hpo pathway. Our analysis of the human orthologs of Hpo,
Sav and Wts uncovered three major sub-clusters linked to the core
kinase module: MOB1-LATS, SARAH and STRIPAK (Fig 3A). MOB1-
LATS represents the smallest cluster within this module. It contains
the Mats homologs MOB1A and MOB1B which we found in com-
plexes with the protein kinases ST38L and LATS1. LATS1 has been
shown to act as a substrate for MST1 but serves also as upstream
kinase for the phosphorylation and inactivation of YAP1. Under the
experimental conditions applied we identified stable kinase sub-
strate complexes between LATS1 and YAP1, but not between MST1
and LATS1. In MST1/2 complexes we found all human SARAH
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Figure 3. The human STRIPAK complex associates with RASF3 and MST1/2.
A High-resolution interaction map of the human Hpo core kinase cassette and the STRIPAK complex. Bait proteins are indicated as hexagons, prey proteins as circles.
Node color corresponds to the modules defined in Fig 2. Solid lines are interactions found by AP-MS in this study, dotted, red lines are obtained from public protein
interaction databases. The Hpo kinase homologs MST1 and MST2 interact with SAV1 and all RASF proteins in the SARAH module. The assembly of MOB1A/B and
LATS1 forms the downstream kinase cascade of Hpo and associates with the LATS1 substrate YAP1. MST1 and RASF3 interact with the STRIPAK complexes.
B Interactions between SARAH domain proteins MST1/2 and RASF1–6. All RASF proteins interact with MSTs but not with other RASF proteins or SAV1. MST1/2 form
hetero-dimers with each other, as well as the remaining SARAH domain proteins. Interactions identified with MST1/2 were quantified (red lines) by the average
intensity of the three most intense precursors ions per protein. The line width represents protein abundance relative to the respective bait. The strongest
interactions occur between the MST1/2 heterodimer, whereas the predominant RASF-MST interaction was RASF2 and MST1, or RASF2 and MST2, respectively.
Green edges represent interactions that have not been quantified.
C Abundance changes of interacting proteins of MST1 upon okadaic acid stimulation. HEK293 cells expressing Strep-HA tagged MST1 were treated with 100 nM
okadaic acid (OA) for 2 h. Left axis represents the protein abundance relative to MST1. Right axis (log fold change; dotted line) is the logarithmic fold change of the
relative abundance of proteins bound to MST1, following OA treatment. The purified MST1 complexes contained an increased amount of STRIPAK associated
proteins, whereas SARAH module components only show marginal changes. Similar results were obtained for MST2 (Supplementary Figure S4C). Error bars indicate
standard deviation from biological triplicates. Asterisks indicate t-test statistical significance (*P < 0.05; **P < 0.01).
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domain-containing proteins which include, apart from MST1/2, the
Ras-association domain proteins RASF1-6 and the WW domain pro-
tein SAV1 (Fig 3A). It has been proposed that SARAH domain
proteins undergo complex formation via homotypic dimerization
with other SARAH domain proteins (Scheel & Hofmann, 2003) and
some of these interactions have been linked to the regulation of
MST1/2 kinase (Praskova et al, 2004; Polesello et al, 2006; Avruch
et al, 2009). It is not clear, however, whether the full range of com-
binatorial possibilities indeed occurs or whether only a subset of
dimeric SARAH domain pairs can be formed in human cells. To
address this question and to resolve potential differences in concur-
rent SARAH domain complexes, we included all human SARAH pro-
teins as baits in our AP-MS analysis. In contrast to published
protein interaction data (Donninger et al, 2011), we observed a high
degree of selectivity in binding between the two Hpo kinases and
the remaining SARAH domain proteins. Only MST1/2 could
undergo combinatorial complex formation with the other SARAH
domain proteins, whereas RASF1-6 and SAV1 complexes exclusively
contained either MST1 or MST2, but none of the other SARAH pro-
teins (Fig 3B). Based on the average of the three most abundant pre-
cursor ion intensities per protein (TOP3) (Silva et al, 2006; Rinner
et al, 2007; Glatter et al, 2011) we could quantified the relative
abundance of endogenous MST1/2 interactors. Since SH-tagged
MST1 and MST2 are expressed to similar levels, which correspond
well to the levels of endogenous proteins (Supplementary Figure
S4A and B) (Glatter et al, 2009) the obtained quantitative data are
likely to reflect relative abundances of endogenous MST1 and MST2
complexes. The MST1-MST2 hetero-dimer represents the most
abundant SARAH domain assembly, followed by complexes
between MST1/MST2 and RASF2 or SAV1 (Fig 3B). This result
suggests a system of 15 potentially concurrent SARAH protein sub-
complexes and raises the question whether these sub-complexes
may have specific biochemical functions. The identification of
cellular proteins that bind both RASF family members and MST1/2
may provide a first hint at potential functional diversification of
found RASF-MST assemblies. RASF1/3/5, for example, were identi-
fied in complexes with MAP1S and MAP1B, two-microtubule-
associated proteins also found in MST1/2 complexes, suggesting a
potential role for this subset of RASF-MST assemblies in controlling
microtubules. In this regard it has been reported that RASF1 stabi-
lizes microtubules through interaction with MAP1 proteins (Dallol
et al, 2004; Song et al, 2005). In contrast, the exportin protein XPO6
co-purified exclusively with RASF1 and MST1, and the vesicle-
associated membrane protein-associated protein VAPA and VAPB
were found only in RASF3 and MST1 complexes, providing further
evidence for potential functional diversification of RASF-Hpo kinase
complexes.
In this context the analysis of RASF3 complexes revealed an
association with eight members of the human STRIPAK complex.
Two of these components (STRN3, SLMAP) were also detected in
MST1 complexes, suggesting that human STRIPAK can bind to both
MST1, RASF3 or complexes thereof. No STRIPAK components were
detected with other RASF family members (Fig 3A). It appears that
the STRIPAK-Hpo interaction is conserved since we previously
could show that subunits of the Drosophila STRIPAK complex also
bind to Hpo and dRASSF, where they act as negative regulators of
Hpo signaling by recruitment of the protein phosphatase PP2A
(Ribeiro et al, 2010). The phosphatase inhibitor okadaic acid
(OA) has been shown to activate the human Hpo pathway
(Taylor et al, 1996; O’Neill et al, 2004; Guo et al, 2011) and thus
may change the composition of MST1/2 complexes. Based on the
average TOP3 intensities precursor intensities, we measured the rel-
ative abundance of MST1/2-associated proteins in the presence or
absence of OA (Fig 3C, Supplementary Figure S4C). Whereas inter-
actions with SARAH domain proteins were largely unaffected or
mildly decreased upon OA treatment, we found a strong increase of
all STRIPAK subunits associated with MST1/2 in OA-treated cells
even though overall amounts of STRIPAK components STRN and
SLMAP are not affected by OA as determined by Western blotting
(Supplementary Figure 4D). This indicates that under exponential
growth conditions, the amount of STRIPAK proteins bound to
human Hpo is relatively low compared to the amount of associated
SARAH proteins, but may significantly increase upon changes in
protein phosphorylation as illustrated by OA treatment (Fig 3C).
By including STRN, STRN3 and SLMAP as baits we could detect
all known STRIPAK subunits including the GCK-III subfamily of
Ste20 protein kinases, STK24 and MST4, and subunits of the protein
phosphatase PP2A. Interestingly, we found that only a specific sub-
type of the STRIPAK complex containing SLMAP, FGOP1 and SIKE1,
but not CTTNBP2 and CTTNBP2NL, binds to Hpo kinases and
RASF3. In comparison, the related kinases STK23, STK24 and MST4
are able to bind both subtypes of STRIPAK (Goudreault et al, 2009).
Whether STRIPAK-mediated recruitment of PP2A leads to dephos-
phorylation and inhibition of the human Hpo kinases like in
Drosophila remains to be tested. Our data on the topology of the
Hpo kinase core complexes suggest that Hpo kinase, rather than
being a single kinase unit, represents a highly dynamic system of
multiple concurrent kinase complexes, some of which may be regu-
lated by a specific human STRIPAK-PP2A complex.
The PP1-ASPP module provides links to apico-basal and
planar cell polarity
Apart from the canonical Hpo kinase cassette, we identified a
module linked to YAP1 which is centered around the serine protein
phosphatase 1 (PP1) and contains several proteins associated with
the control of apico-basal cell polarity (ABCP) as well as planar cell
polarity (PCP). We initially found PP1 together with ASPP2 (Apop-
tosis-stimulating of p53 protein 2) in YAP1 complexes. Analysis of
ASPP2, its paralog ASPP1, and the PP1G catalytic subunit as AP-MS
baits resulted in an extended network which includes all three PP1
catalytic subunits (PP1A, PP1B, PP1G) and multiple regulatory
subunits (Fig 4A; Supplementary Table S2). Both ASPP1 and ASPP2
can interact with all PP1 catalytic subunits, the coiled-coil proteins
CC85B and CC85C and the Ras-association domain family proteins
RASF7, RASF8 and RASF9. We subsequently included RASF7/8/9/10
as baits in our AP-MS analysis. Interaction data from these poorly
studied proteins further refined the ASPP/RASF/PP1 sub-network. As
ASPP1 and ASPP2 do not interact with each other, we suggest the for-
mation of mutually exclusive ASPP/RASF/PP1 complex isoforms.
Whereas all four RASF proteins share the association with PP1 and
ASPP, the individual RASF members also form paralog-specific
complexes. In both RASF9 as well as RASF10 complexes we found
the Drosophila homologs of the segment polarity protein Dishevelled
DVL1/2/3, together VANG1 and PRIC1/3, which have been impli-
cated in the PCP pathway (Gubb et al, 1999; Song et al, 2010).
RASF9/10 also interact with the alpha and beta subunits of casein
Molecular Systems Biology 9: 713 | 2013 ª 2013 The Authors.
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kinase II (CSK21 and CSK2B), the upstream kinases which phosphor-
ylate and activate DVL proteins (Song et al, 2000; Bernatik et al,
2011).
PARD3, a key apical determinant (St Johnston & Ahringer,
2010), was found in complexes containing ASPP2, RASF9 and
RASF10. Such a PP1-PARD3 complex has been reported before,
where PP1A directly dephosphorylates PARD3 to stabilize a func-
tional Par/aPKC complex (Traweger et al, 2008). PARD3 has been
shown to form the Par polarity complex together with PARD6 and
the atypical protein kinase C (aPCK), two proteins we identified in
L2GL1 complexes described below (Petronczki & Knoblich, 2001).
We could not detect any of the RASF9/10-associated cell polarity
proteins by using the related RASF7/8 proteins as baits.
Besides the mentioned cell polarity regulators in RASF9/10 com-
plexes, we also found the PDZ protein SCRIB in PP1G phosphatase
complexes. SCRIB is the human ortholog of Drosophila Scribble, a
protein that controls apico-basal polarity together with Lgl and Dlg
and has been linked to Hpo signaling (Bilder et al, 2000; Cordenonsi
et al, 2011; Doggett et al, 2011). In this regard, Scribble has been
genetically linked in Drosophila to PP1 phosphatase, via PP1R7
(Sds22) (Jiang et al, 2011), a regulatory PP1 subunit we also identi-
fied with PP1G. Whether PP1R7 and SCRIB interact together with
PP1G in the same sub-complex, remains to be tested.
Our AP-MS data also revealed previously known PP1 sub-
complexes including the PTW/PP1 phosphatase complex formed by
the PP1G interacting proteins PP1RA, WDR82 and TOX4, which has
been shown to regulate chromatin structure during the cell cycle
(Lee et al, 2010) and the PP1G-associated URI prefoldin complex
linked to S6 kinase signaling (Djouder et al, 2007). Collectively the
presence of the different groups of cell polarity proteins in the PP1-
ASPP module suggest a significant role for this module in control-
ling cell polarity processes by a variety of molecular mechanisms,
some of which are likely to involve established Hpo signaling
components.
PP1/ASPP2 complexes promote YAP1 activity
Since we found PP1A and ASPP2 in complexes with YAP1 we
wanted to test whether these proteins or other components from the
PP1 module might regulate YAP1-dependent transcription. We
applied a dual luciferase reporter (DLR) system containing a pro-
moter with TEAD transcription factor binding sites to measure
YAP1/TEAD transcriptional activity in response to transient over-
expression of PP1 network components in HEK-293-Flp cells
expressing Strep-HA tagged YAP1 (SH-YAP1) (Mahoney et al,
2005). We generated a set of constructs for the expression of PP1
network components and validated transgenic expression of 24
components from the PP1-ASPP module by Western blotting (Sup-
plementary Figure S5A). We used MST1 and YAP1 as negative and
positive controls to ensure assay specificity (Supplementary Figure
S5B). Similar to earlier reports, MST1 decreased (Ota & Sasaki,
2008) whereas YAP1 overexpression increased transcriptional activ-
ity of the TEAD reporter (Lamar et al, 2012). Upon transient expres-
sion of the corresponding transgenes, we found that among the 24
components tested, overexpression of PP1G, PP1A and ASPP2 most
strongly enhanced the expression from the TEAD luciferase reporter
construct (Fig 4B). The observed activation was dependent on
TEAD binding sites in the promoter of the luciferase reporter con-
struct (Supplementary Figure S5C). Remarkably, the related proteins
PP1B and ASPP1 had no significant effects. This pattern is in agree-
ment with our interaction data, where we only found ASPP2 and
PP1A to bind YAP1 but not ASPP1 and PP1B. We next performed
these experiments under conditions where YAP1 expression was
silenced by siRNA treatment to test whether the observed activation
by PP1 is dependent on YAP1 levels. The results clearly showed that
the observed activation of the TEAD luciferase reporter was signifi-
cantly reduced when YAP1 expression was silenced by siRNA
(Fig 4C). In conclusion, the data indicate that PP1A, PP1G, and
ASPP2 overexpression increases YAP1-mediated transcriptional
activity and suggest a potential role for ASPP2 as the YAP1-interact-
ing determinant of the PP1-ASPP module providing substrate speci-
ficity for PP1A and PP1G. Previous work suggests that the ASPP2/
PP1 complex can promote TAZ activity by reversing LATS-mediated
inhibitory TAZ phosphorylation on Ser-89 and Ser-311 (Liu et al,
2011). Our results are consistent with a similar role for ASPP2/PP1
in antagonizing YAP1 inactivation by LATS1/2.
A cell polarity network linked to L2GL1, KIBRA, MERL and YAP1
The Hpo core kinase cassette has long been recognized as the
major upstream regulatory module of YAP1 (Huang et al, 2005).
Recent studies, however, have indicated multiple modes of Hpo-
independent YAP1 regulation, which involve signals from cell-cell
contacts (Varelas et al, 2010; Wang et al, 2011; Zhao et al, 2011),
mechanical stress (Dupont et al, 2011; Wada et al, 2011) and cell
polarity (Chen et al, 2010; Grzeschik et al, 2010; Ling et al, 2010;
Robinson et al, 2010; Doggett et al, 2011), suggesting a role for
YAP1 as a major hub for signal integration. Indeed, we found 30
Figure 4. The ASPP-PP1 module provides links to cell polarity and modulates YAP1 mediated transcriptional activity.
A Detailed view of the PP1-ASPP module. The PP1-ASPP network was defined by interaction data from ASPP1/2, PP1G, and RASF7/8/9/10 purification experiments.
Three different cell polarity complexes could be linked to the PP1-ASSP network (highlighted in blue). The polarity determinant SCRIB (Scribble) was found with
PP1G, the Par polarity complex component PARD3 was identified with RASF9/10 and ASPP2, and proteins linked to planar cell polarity (VANG1, PRIC1/3 and DVL1/2/3)
were co-purified with RASF9/10. Node color corresponds to the modules defined in Fig 2.
B PP1-ASPP network components affect YAP1 transcriptional activity. To test whether overexpression of PP1-ASPP network components could influence TEAD promoter
activity, HEK293-Flp cells expressing SH-YAP1 were co-transfected with a firefly luciferase reporter construct containing four TEAD transcription factor binding sites
together with constructs for the overexpression of indicated PP1-ASPP network components (left panel). The measured firefly activities were normalized to the
activity of a constitutively co-expressing Renilla luciferase and a vector control. Error bars indicate standard deviation from biological triplicates. Asterisks indicate
t-test statistical significance (*P < 0.05; **P < 0.01).
C PP1A mediated activation of the TEAD promoter activity is dependent on YAP1. Dual luciferase assays have been performed following co-transfection of indicated
siRNA and PP1A expression construct. Error bars represent standard deviation from biological triplicates. Asterisks indicate t-test statistical significance (*P < 0.05;
**P < 0.01).
◂
Molecular Systems Biology 9: 713 | 2013 ª 2013 The Authors.
Molecular Systems Biology Protein interaction landscape of human Hpo signaling Simon Hauri et al
8
HCIPs in YAP1 complexes, 21 of which have not been observed
previously. Besides the interactions with canonical Hpo compo-
nents, including the established upstream inhibitory kinase LATS1
or the transcription factor TEAD3, we identified a large group of
proteins linked to cell polarity and cell junction complexes. To
gain a more detailed view on the organization of this cell polarity
network linked to YAP1 we included several proteins of the cell
junction complex (AMOT, MPP5, LIN7A), the FERM domain pro-
teins (FRMD3, FRMD5, FRMD6, E41L3) as baits in our AP-MS
experiments. These bait proteins complemented the Hpo compo-
nents previously linked to cell polarity (L2GL1) or the cell cortex
(MERL, KIBRA) (Fig 5).
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Figure 5. The YAP1 associated polarity network contains multiple FERM and PDZ domain proteins.
Besides TEAD3, YAP1 binds to an extended network of FERM, PDZ and L27 domain proteins, which contains AMOT as a central node. AMOT and AMOL1 connect FERM domain
proteins with the tight junction associated L27 and PDZ proteins and also directly binds to YAP1. Asterisks (*) refers to supplementary Fig S6. Node and edge color corresponds
to the modules defined in Fig 2. Par polarity complexes and apicobasal polarity proteins are indicated with red boxes.
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Analysis of complexes containing L2GL1, the human ortholog of
Drosophila tumor suppressor lethal giant larvae (Lgl), revealed the
presence of all major components of the Par polarity complex. They
include the aPKC subunits KPCI and KPCZ, SQSTM, a protein previ-
ously found associated with aPKC (Sowa et al, 2009), and the cell
polarity proteins PARD6B and PAR6G. We did not find any interac-
tions between L2GL1 and other canonical Hpo pathway members,
however.
FRMD6 is the closest human homolog of the Drosophila protein
Expanded (Ex). Ex has been shown to associate with Mer and Kibra to
from a complex involved in the regulation of Hpo kinase activity (Ha-
maratoglu et al, 2006; Baumgartner et al, 2010; Genevet et al, 2010;
Yu et al, 2010). We could not confirm any homologous interactions
with FRMD6 (or FRMD3 and FRMD5, Supplementary Table S2) but
instead found interactions between YAP1,MERL, KIBRA and the junc-
tional protein AMOT (Angiomotin). YAP1 binds directly through its
WW domains to the PPxY motif of Angiomotin and its paralogues
(AMOL1 and AMOL2) (Wang et al, 2011; Zhao et al, 2011). Drosoph-
ila Ex also has been found to bind the Yki WW domain by its PPxY
motif and inhibit Yki activity (Badouel et al, 2009; Oh et al, 2009).
The level of evolutionary Hpo pathway conservation between Dro-
sophila and higher eukaryotes is currently of great interest. The simi-
larity in interaction partners has led to the suggestion that AMOT
might be the functional homolog of Ex in mammals (Genevet & Ta-
pon, 2011) and a recent evolutionary study concluded that FRMD6 is
unlikely to be the functional homolog of Ex, as it lacks a PPxY motif-
containing C-terminal domain (Bossuyt et al, 2013). These notions
are both supported by our experimental data.
Analogous to Ex in Drosophila, AMOT forms a highly inter-
linked network with proteins found in apico-basal polarity com-
plexes (LIN7C, MPP5, MPDZ, INADL), which share a characteristic
L27 protein-binding domain (Fig 5). L27 domains form heterotetra-
meric complexes with each other (Feng et al, 2004) and show sig-
nificant enrichment in our network (Supplementary Figure S2B).
When we used LIN7A as bait, we found six additional L27 domain
proteins to the already mentioned ones: LIN7A itself and the MAG-
UK proteins CSKP, MPP2/6/7 and DLG1, the homolog of Drosoph-
ila Discs large 1 (Dlg). Two other protein binding domains –
FERM and PDZ – were also highly overrepresented in our network
(Supplementary Figure S3B). The FERM domains are often found
in proteins that interface between membrane associated proteins
and the cytoskeleton (Chishti et al, 1998). Eight of the nine FERM
containing proteins from our AP-MS dataset are exclusively found
in the cell polarity module. Among the novel PDZ proteins associ-
ated with YAP1, we found RAPGEF2/6 that function as GEFs for
the Ras GTPase RAP1. RAP1 plays a role in the formation of
adherence junctions (AJ) and RAPGEF1 was shown to be required
for AJ maturation (Dube et al, 2008) which may suggest a link
between these processes and the control of YAP1. Other work has
suggested interactions between RAPGEF6 and another WW pro-
tein, BAG3 which is involved in mechanotransduction (Ulbricht
et al, 2013).
Cell-cell contacts control YAP1 complex formation with apico-
basal cell polarity proteins
YAP1 nuclear localization is enhanced upon low-density growth or
disruption of cell-cell contacts (Zhao et al, 2007; Ota & Sasaki, 2008;
Varelas et al, 2010; Schlegelmilch et al, 2011) which raises the
questions how YAP1 complex formation may be affected under
these conditions. We therefore monitored the abundance of YAP1
interacting proteins in cells subjected to non-adhesive growth over a
time course of one hour (Fig 6A), which has been shown to result
in YAP1 de-repression (Zhao et al, 2012). Based on the average
TOP3 intensity (see above) we reliably quantified 20 YAP1-associated
proteins across the entire time course. Consistent with the observa-
tion that YAP1 nuclear localization is enhanced upon disruption of
cell-cell contacts and cell-matrix attachment, we found its association
with TEAD3 transcription factor increased when cell are grown in
suspension. We also noticed a concerted drop in cell polarity proteins
(AMOT, AMOL1, LIN7C, INADL, MPP5 and MPDZ) associated with
YAP1 upon disruption of cell-cell contacts. Next we analyzed YAP1
complexes under conditions where cell-cell contacts were reduced by
growing cells at low density (Fig 6B). Similar to the results obtained
for suspension cell growth these experiments revealed a significant
drop of apico-basal cell polarity proteins (AMOT, AMOL1, LIN7C,
INADL, MPP5 and MPDZ) when cells were grown at low density.
When we analyzed YAP1 dependent activation of the TEAD lucifer-
ase promoter we found a gradual increase in activity with decreasing
cell density. These results clearly show that the interaction of YAP1
with the cell polarity network is highly dynamic and thus suggests a
potential role for the polarity network as an integrated signaling sys-
tem that controls the transcriptional co-activator YAP1 in response to
changes at intercellular junctions.
Discussion
Metazoan tissue homeostasis at the cellular level emerges from the
interplay of concurrent signaling systems that integrate and translate
information from neighboring cells, growth factors and mechanical
forces to coordinate cell growth, proliferation, apoptosis as well as
cell shape changes in a tissue context. Initial models on the regula-
tion of metazoan tissue cell growth by the Hpo pathway were
centered on the Hpo core kinase cassette involving a linear array of
regulatory relationships among canonical Hpo core components that
control the transcriptional effector Yki/YAP. But what are the mole-
cules and mechanisms that link processes relevant for tissue integ-
rity such as mechanotransduction or cell polarity to growth control
by the Hpo pathway? Recent genetic and biochemical data on
individual pathway components first revealed links between the
Hpo pathway and proteins at the cellular membrane and intercellu-
lar junction (Piccolo & Cordenonsi, 2013). This suggests close links
between epithelial plasticity, cell polarity and growth control by
Yki/YAP (Piccolo & Cordenonsi, 2013). However, most of these
recent insights were obtained on isolated Hpo pathway components
studied in different cellular contexts using different biochemical
approaches, which complicates the integration of such information
into coherent models of tissue growth.
In this study we present an integrated model on the biochemical
landscape underlying human Hpo signaling using an unbiased
proteomics approach in a defined cellular context. The integrated
view presented here provides several new insights into the global
biochemical organization of the Hpo pathway and its relationship to
coexisting cell polarity modules. First, human Hpo kinase can be
viewed as a system of co-existing kinase sub-complexes, which are
mostly based on homotypic SARAH domain interactions involving
Molecular Systems Biology 9: 713 | 2013 ª 2013 The Authors.
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all nine human SARAH domain proteins. These sub-complexes
showed overlapping but also highly specific interactions with other
cellular proteins indicating potential functional diversification of
Hpo kinase sub-complexes. Furthermore, human Hpo kinase can
bind to STRIPAK, a protein phosphatase 2 complex that binds and
negatively regulates Hpo in Drosophila (Ribeiro et al, 2010). Given
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Figure 6. YAP1 complex formation is affected by cell-cell contacts.
A Schematic overview on the analysis of YAP1 complex dynamics following disruption of cell-cell contacts. SH-YAP1-expressing HEK293 cells are grown on plates or
subjected to suspension growth for indicated time points before quantitative AP-MS analysis. Protein abundance relative to YAP1 is measured on the basis of the
average intensity of the three most intense peptide precursor ions. The apico-basal polarity proteins AMOT, AMOL1, LIN7C, INADL, MPP5 and MPDZ are decreased,
whereas the transcription factor TEAD3 is increased. Average relative abundances of YAP1 associated proteins obtained from three independent experiments are
plotted. Error bars represent standard deviation. Asterisks indicate t-test statistical significance (*P < 0.05; **P < 0.01).
B Quantitative AP-MS of YAP1 complexes isolated from cells grown at high and low density. The log2 ratio of measured protein abundances between low and high
density conditions was used to visualize YAP1 complex changes. Negative ratios indicate a decrease, positive ratios represent an increase of proteins binding YAP1 at
low cell density. Error bars: standard deviation from biological triplicates. Asterisks: t-test statistical significance (*P < 0.05; **P < 0.01).
C Cell density affects TEAD promoter activity in HEK-293 cells. HEK-Flp cells expressing SH-YAP1 were grown at indicated densities and tested for TEAD luciferase
promoter activity. Error bars indicate standard deviation from biological triplicates. Asterisks indicate t-test statistical significance (*P < 0.05; **P < 0.01).
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this evolutionary conservation it remains to be seen whether STRI-
PAK may also act as a negative regulator of MST1/2 kinase in
human cells. Second, clustering of AP-MS data revealed that cell
polarity proteins interacting with Hpo core components can be
assigned to two separate modules (‘ASPP/PP1’ and ‘Polarity Net-
work’) that are biochemically distinct from the Hpo core kinase
module. The modular structure of the Hpo interaction proteome
together with our findings that all three modules converge on the
major Hpo effector YAP1 is consistent with an emerging view that
cell polarity signaling may control YAP1 in parallel or even indepen-
dent of the canonical Hpo core kinase module. This contrasts
models based on genetic studies in Drosophila which link cell polar-
ity regulators upstream of Hpo (Hamaratoglu et al, 2006; Ling et al,
2010). Third, our results also show that the interaction proteome of
major Hpo pathway components is highly dynamic and changes in
response to an altered cellular environment. In YAP1 complexes we
found a strong decrease in abundance of cell polarity proteins upon
disruption of cell-cell contacts. These results suggest that cell
polarity and cell junction complexes may constitute dynamic
signaling modules that relay information on tissue integrity towards
the major Hpo effector YAP1.
Besides these general conclusions on the overall organization of
the Hpo pathway interaction proteome, this work identified 343
new protein interactions for human Hpo components. These interac-
tions represent an important resource for directing future functional
studies to better understand the detailed mechanisms underlying the
molecular coupling of cell polarity signaling to cell growth control
by the human Hpo pathway.
Materials and Methods
Expression constructs
To generate expression vectors for tetracycline-inducible expression
of N-terminally Strep-HA-tagged bait proteins, human ORFs
provided as pDONRTM223 vectors were selected from a Gateway
compatible human orfeome collection (horfeome v5.1, Thermo
Fisher Scientific, Waltham, MA, USA) for LR recombination with
the destination vector pcDNA5/FRT/TO/SH/GW (Glatter et al,
2009). Genes not present in the human orfeome collection were
amplified from the MegaMan Human Transcriptome Library
(Agilent Technologies, Santa Clara, CA, USA) by PCR, unless stated
otherwise (Supplementary Table S1), and cloned into entry vectors
by TOPO cloning (pENTRTM-TOPO) or BP clonase reaction
(pDONRTM223 or pDONRTM/Zeo; Life Technologies, Carlsbad, CA,
USA).
Stable cell line generation
HEK Flp-InTM 293 T-Rex cells (Life Technologies) containing a single
genomic FRT site and stably expressing the tet repressor were
cultured in DMEM medium (4.5 g/l glucose, 2 mM L-glutamine; Life
Technologies) supplemented with 10% FCS, 50 lg/ml penicillin,
50 lg/ml streptomycin, 100 lg/ml zeocin and 15 lg/ml blasticidin.
The medium was exchanged with DMEM medium (10% FCS,
50 lg/ml penicillin, 50 lg/ml streptomycin) before transfection.
For cell line generation, Flp-In HEK293 cells were co-transfected
with the corresponding expression plasmids and the pOG44 vector
(Life Technologies) for co-expression of the Flp-recombinase using
the FuGENE 6 transfection reagent (Promega, Fitchburg, WI, USA).
Two days after transfection, cells were selected in hygromycin-
containing medium (100 lg/ml) for 2–3 weeks.
Protein purification
Stable isogenic cell pools were grown in four 14-cm Nunclon dishes
to 80% confluency, induced with 1.3 lg/ml doxycline for 24 h for
the expression of SH-tagged bait proteins and harvested with PBS
containing 10 mM EDTA. Cells were collected, frozen in liquid
nitrogen and stored at 80°C prior to protein complex purification.
The frozen cell pellets were resuspended in 4 ml HNN lysis
buffer [50 mM HEPES pH 7.5, 150 mM NaCl, 50 mM NaF, 0.5%
Igepal CA-630 (Nonidet P-40 Substitute), 200 lM Na3VO4, 1 mM
PMSF, 20 lg/ml Avidin and 1x Protease Inhibitor mix (Sigma-
Aldrich, St. Louis, MO, USA)] and incubated on ice for 10 min.
Insoluble material was removed by centrifugation. Cleared lysates
were loaded on a pre-equilibrated spin column (Bio-Rad, Her-
cules, CA, USA) containing 50 ll Strep-Tactin sepharose beads
(IBA GmbH, Go¨ttingen, Germany). The beads were washed two
times with 1 ml HNN lysis buffer and three times with HNN buf-
fer (50 mM HEPES pH 7.5, 150 mM NaCl, 50 mM NaF). Bound
proteins were eluted with 600 ll 0.5 mM biotin in HNN buffer.
To remove the biotin, eluted samples were TCA precipitated,
washed with acetone, air-dried and re-solubilized in 50 ll 8 M
urea in 50 mM NH4HCO3 pH 8.8. Cysteine bonds were reduced
with 5 mM TCEP for 30 min at 37°C and alkylated in 10 mM io-
doacetamide for 30 min at room temperature in the dark. Samples
were diluted with NH4HCO3 to 1.5 M urea and digested with 1 lg
trypsin (Promega) overnight at 37°C. The peptides were purified
using C18 microspin columns (The Nest Group Inc., Southbor-
ough, MA, USA) according to the protocol of the manufacturer,
resolved in 0.1% formic acid, 1% acetonitrile for mass spectrome-
try analysis.
Mass spectrometry
LC-MS/MS analysis was performed on a LTQ Orbitrap XL mass
spectrometer (Thermo Fisher Scientific). Peptide separation was car-
ried out by a Proxeon EASY-nLC II liquid chromatography system
(Thermo Fisher Scientific) connected to an RP-HPLC column
(75 lm x 10 cm) packed with Magic C18 AQ (3 lm) resin (WICOM
International, Maienfeld, Switzerland). Solvent A was used as
RP-HPLC stationary phase (0.1% formic acid, 2% acetonitrile). Sol-
vent B (mobile phase; 0.1% formic acid, 98% acetonitrile) was used
to run a linear gradient from 5 to 35% over 60 min at a flow rate of
300 nl/min. The data acquisition mode was set to obtain one high
resolution MS scan in the Orbitrap (60,000 @ 400 m/z). The 6 most
abundant ions from the first MS scan were fragmented by collision-
induced dissociation (CID) and MS/MS fragment ion spectra were
acquired in the linear trap quadrupole (LTQ). Charge state screening
was enabled and unassigned or singly charged ions were rejected.
The dynamic exclusion window was set to 15 s and limited to 300
entries. Only MS precursors that exceeded a threshold of 150 ion
counts were allowed to trigger MS/MS scans. The ion accumulation
time was set to 500 ms (MS) and 250 ms (MS/MS) using a target
setting of 106 (MS) and 104 (MS/MS) ions. After every replicate set,
a peptide reference sample containing 200 fmol of human [Glu1]-
Fibrinopeptide B (Sigma-Aldrich) was analyzed to monitor the LC-
MS/MS systems performance.
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Protein identification
Acquired spectra were searched with X!Tandem (Craig & Beavis,
2004) against the canonical human proteome reference dataset
(http://www.uniprot.org/), extended with reverse decoy sequences
for all entries. The search parameters were set to include only fully
tryptic peptides (KR/P) containing up to two missed cleavages.
Carbamidomethyl (+57.021465 amu) on Cys was set as static
peptide modification. Oxidation (+15.99492 amu) on Met and
phosphorylation (+79.966331 amu) on Ser, Thr, Tyr were set as
dynamic peptide modifications. The precursor mass tolerance was
set to 25 ppm, the fragment mass error tolerance to 0.5 Da.
Obtained peptide spectrum matches were statistically evaluated
using PeptideProphet and protein inference by ProteinProphet,
both part of the Trans Proteomic Pipeline (TPP, v.4.5.1) (Deutsch
et al, 2010). A minimum protein probability of 0.9 was set to
match a false discovery rate (FDR) of < 1%. The resulting pep.xml
and prot.xml files were used as input for the spectral counting
software tool Abacus to calculate spectral counts and NSAF values
(Fermin et al, 2011).
Evaluation of high confidence interacting proteins (HCIP)
Adjusted NSAF values of identified co-purified proteins were com-
pared to a mock AP control dataset consisting of 62 StrepHA-GFP
or 12 StrepHA-RFP-NLS purification experiments. GFP and RFP
control datasets have been deposited in the CRAPome contaminant
repository for affinity purification (Mellacheruvu et al, 2013). The
protein abundance in the control dataset was estimated by averag-
ing the 10 highest NSAF values per protein among all 74 measure-
ments. In order for candidate interactions to pass high confidence
filtering, the enrichment threshold over the control dataset was set
to > 10. Adjusted NSAF values were also used to calculate WDN-
scores of all the potential interactions (Behrends et al, 2010). A
simulated data matrix was used to calculate the WD-score thresh-
old below which 95% of the simulated data falls. All raw WD-
scores were normalized to this value. All interactions that have a
WDN-score greater or equal to 1 passed this filtering step. From
the high confidence interaction dataset (control ratio and WDN-
score) a gene distance matrix (GDM) was generated, based on an
uncentered Pearson distance metric, using the software tool Multi-
Experiment Viewer (Saeed et al, 2003) (http://www.tm4.org/mev/
). To increase sensitivity, the obtained distances were mapped to
the unfiltered PPI dataset and sub-threshold interactions were
rescued, if the distance was greater than zero (n = 44 protein
interactions).
Label free quantification of MST1 and YAP1 interactions
HEK Flp-InTM 293 T-Rex cells (Life Technologies) expressing
SH-MST1 and SH-MST2 were treated with 100 nM okadaic acid
(LC Laboratories, Woburn, MA, USA) for 2 h. Affinity purification
and mass spectrometry analysis was carried out as described above.
For cell density AP-MS analysis of YAP1 complexes, HEK Flp-InTM
293 T-Rex cells (Life Technologies) expressing SH-YAP1 were either
harvested at 30% (low density) or 80% (high density) confluency.
For the suspension time course experiments the SH-YAP1 expressing
cells were grown to 80% confluency and forced into suspension by
treatment with Trypsin-EDTA (Life Technologies) and kept on a tube
rotator for 0, 10, 30, and 60 min. The cells were pelleted by centrifu-
gation, washed with PBS and frozen in liquid nitrogen to be stored at
80°C prior to protein complex purification. The affinity purification
and mass spectrometry analysis was performed as described above.
Label-free quantification to estimate relative protein abundances
was performed by averaging the three most intense peptide precursor
ions for identified proteins, using the commercial software tool Pro-
genesis LC-MS (Nonlinear USA Inc., Durham, NC, USA). Raw abun-
dance values were normalized to the bait protein intensity.
Network visualization and accessed public protein
interaction databases
Protein Interaction data was visualized with Cytoscape 2.8.3
(http://www.cytoscape.org) (Shannon et al, 2003). Known interac-
tions were obtained from the protein interaction network analysis
platform PINA (http://cbg.garvan.unsw.edu.au/pina/) (Wu et al,
2009), for the bait proteins used in this study.
Dual luciferase reporter assay
Flp-In HEK293 SH-YAP1 cells were grown to 50% confluency in a
six-well plate format. Where indicated, YAP1 expression was
induced with 500 ng/ml doxycline for 6 h prior transfection. The
cells were transfected with 80 ng pGL3-4xGTIIC-49 (firefly luciferase
reporter with TEAD binding sites) or pGL3-49 (negative control; no
TEAD binding sites), and 0.3 ng pRL-CMV (Renilla luciferase;
Promega) using the transfection reagent FuGENE 6 (Promega). For
protein overexpression, 100 ng of pDEST40 (Life Technologies)
expressing the corresponding V5-tagged Hpo network components
were co-tranfected with the luciferase plasmids. The transfected cells
were kept under doxycycline induction for the next 24 h. For RNAi
treatment the cells were transfected with 50 nM YAP1 or control
Silencer Select siRNA (Life Technologies) 24 h prior transfection of
the expression constructs using FuGENE HD (Promega), DMEM and
FBS was removed and the cells were washed with PBS. Cell lysis for
the Dual-Luciferase Reporter Assay (DLR; Promega) were performed
according to the manufacturer’s instructions. The luciferase signals
were measured with a Synergy HT Multi-Mode microplate reader
(BioTek Instruments Inc., Winooski, VT, USA). All obtained values
were normalized to the Renilla activity.
For cell density DLR experiments, Flp-In HEK293-SH-YAP1 were
induced with 500 ng/ml doxycline for 24 h and harvested at 5, 10,
20 and 50% confluencies. The DLR assay was performed according
the manufacturer’s instructions. Cell densities were estimated using
the software tool ImageJ (http://rsbweb.nih.gov/ij/) (Schneider
et al, 2012).
Data deposition
The mass spectrometry data from this publication have been sub-
mitted to the PeptideAtlas database (http://www.peptideatlas.org/)
and assigned the identifier PASS00281. The protein interactions
from this publication have been submitted to the IMEx (Orchard
et al, 2012) consortium through IntAct (Aranda et al, 2010) (http://
www.ebi.ac.uk/intact/) and assigned the identifier IM-20985.
Supplementary information for this article is available online:
http://msb.embopress.org
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